Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma

被引：0

作者：

Mariniello, Katia ^{[1
]}

Pittaway, James F. H. ^{[1
]}

Altieri, Barbara ^{[2
]}

Borges, Kleiton Silva ^{[3
,4
]}

Hadjidemetriou, Irene ^{[1
]}

Ribeiro, Claudio ^{[3
,4
]}

Ruiz-Babot, Gerard ^{[3
,5
]}

Tourigny, David S. ^{[6
]}

Lim, Jiang A. ^{[1
]}

Foster, Julie ^{[7
]}

Cleaver, Julie ^{[7
]}

Sosabowski, Jane ^{[7
]}

Rahman, Nafis ^{[8
]}

Doroszko, Milena ^{[8
]}

Hantel, Constanze ^{[9
,10
]}

Sigala, Sandra ^{[11
]}

Abate, Andrea ^{[11
]}

Tamburello, Mariangela ^{[11
]}

Kiseljak-Vassiliades, Katja ^{[12
,13
]}

Wierman, Margaret ^{[12
,13
]}

Hall, Charlotte ^{[1
]}

Parvanta, Laila ^{[14
]}

Abdel-Aziz, Tarek E. ^{[15
]}

Chung, Teng-Teng ^{[16
]}

Marco, Aimee Di ^{[17
]}

Palazzo, Fausto ^{[17
]}

Gomez-Sanchez, Celso E. ^{[18
,19
]}

Taylor, David R. ^{[20
]}

Rayner, Oliver ^{[20
]}

Ronchi, Cristina L. ^{[21
]}

Gaston-Massuet, Carles ^{[1
]}

Sbiera, Silviu ^{[2
]}

Drake, William M. ^{[1
]}

Rognoni, Emanuel ^{[22
]}

Kroiss, Matthias ^{[2
,23
]}

Breault, David T. ^{[3
,4
]}

Fassnacht, Martin ^{[2
]}

Guasti, Leonardo ^{[1
]}

机构：

[1] Queen Mary Univ London, William Harvey Res Inst, Fac Med & Dent, Ctr Endocrinol, London, England

[2] Univ Wurzburg, Univ Hosp, Dept Med, Div Endocrinol & Diabet, Wurzburg, Germany

[3] Harvard Med Sch, Div Endocrinol, Boston Childrens Hosp, Boston, MA USA

[4] Harvard Stem Cell Inst, Cambridge, MA USA

[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Dresden, Germany

[6] Univ Birmingham, Sch Math, Birmingham, England

[7] Queen Mary Univ London, Barts Canc Inst, Barts & London Sch Med & Dent, Ctr Canc Biomarkers & Biotherapeut, Charterhouse Sq, London, England

[8] Univ Turku, Inst Biomed, Turku, Finland

[9] Univ Hosp Zurich USZ, Dept Endocrinol Diabetol & Clin Nutr, Zurich, Switzerland

[10] Univ Zurich UZH, Zurich, Switzerland

[11] Univ Brescia, Dept Mol & Translat Med, Sect Pharmacol, Brescia, Italy

[12] Univ Colorado, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA

[13] Vet Affair Med Ctr, Div Endocrinol Metab & Diabet Rocky Mt Reg, Washington, DC USA

[14] St Bartholomews Hosp, Dept Surg, London, England

[15] Univ Coll London Hosp NHS Fdn Trust, Dept Surg, London, England

[16] Univ Coll London Hosp NHS Fdn Trust, Dept Endocrinol, London, England

[17] Imperial Coll London, Hammersmith Hosp, Dept Endocrine & Thyroid Surg, London, England

[18] Univ Mississippi Med Ctr, GV Sonny Montgomery VA Med Ctr, Endocrine Sect, Jackson, MS USA

[19] Univ Mississippi Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS USA

[20] Kings Coll Hosp London, Dept Clin Biochem Synnovis Analyt, London, England

[21] Univ Birmingham, Inst Metab & Syst Res, Coll Med & Dent Sci, Birmingham, England

[22] Queen Mary Univ London, Blizard Inst, Ctr Cell Biol & Cutaneous Res, Barts & London Sch Med & Dent, London, England

[23] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Internal Med 4, Munich, Germany

来源：

CANCER COMMUNICATIONS | 2025年

关键词：

D O I：

10.1002/cac2.70012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：6

共 50 条

[31] Conjunctival carcinoma as a novel post-stem cell transplantation malignancy
C Hon
W Y Au
R H S Liang
Bone Marrow Transplantation, 2004, 34 : 181 - 182
[32] NUTLIN-3A AS A NOVEL ANTICANCER AGENT FOR ADRENOCORTICAL CARCINOMA WITH CTNNB1 MUTATION
Feng, Chenchen
Chen, Shanwen
JOURNAL OF UROLOGY, 2017, 197 (04): : E475 - E475
[33] Indoleamine2, 3dioxygenase 1 as a Potential Novel Target for Adrenocortical Carcinoma
Tierney, John F.
Vogle, Alyx
Chivukula, Sitaram V.
Min, Irene M.
Scognamiglio, Theresa
Gattuso, Paolo
Pappas, Sam G.
Fahey, Thomas J., III
Keutgen, Xavier M.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S85 - S85
[34] Nutlin-3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
Hui, Wen
Liu, Shenghua
Zheng, Jie
Fang, Zujun
Ding, Qiang
Feng, Chenchen
CANCER MEDICINE, 2018, 7 (04): : 1440 - 1449
[35] A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1
Harada, Ko
Yasuda, Miho
Hasegawa, Kou
Yamazaki, Yuto
Sasano, Hironobu
Otsuka, Fumio
ENDOCRINE JOURNAL, 2019, 66 (08) : 739 - 744
[36] Conjunctival carcinoma as a novel post-stem cell transplantation malignancy
Hon, C
Au, WY
Liang, RHS
BONE MARROW TRANSPLANTATION, 2004, 34 (02) : 181 - 182
[37] DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line
Vilain, E
Guo, WW
Zhang, YH
McCabe, ERB
BIOCHEMICAL AND MOLECULAR MEDICINE, 1997, 61 (01) : 1 - 8
[38] Anti-α-inhibin -: Marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration
Fetsch, PA
Powers, CN
Zakowski, MF
Abati, A
CANCER CYTOPATHOLOGY, 1999, 87 (03): : 168 - 172
[39] A Novel Glycoengineered Humanized Antibody Targeting DLK1 Exhibits Potent Anti-Tumor Activity in DLK1-Expressing Liver Cancer Cell Xenograft Models
Nakamura, Koji
Takahashi, Kota
Sakaguchi, Izumi
Satoh, Takumi
Zhang, Lingyi
Yanai, Hiroyuki
Tsukumo, Yukihito
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (24)
[40] Gil1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma
Ni, Weidong
Yang, Zhaoting
Qi, Wenbo
Cui, Chunai
Cui, Yan
Xuan, Yanhua
HUMAN PATHOLOGY, 2017, 69 : 38 - 45

← 1 2 3 4 5 →